'De-Tangling' Alzheimer's Drug Shows Promise
...he other hand, a Phase II trial of a drug known as pbt2 did show some promising results. According to rese...hers at the University of California, Los Angeles, pbt2 is thought to reduce amyloid plaques by disrupting..., involved 78 people with mild Alzheimer's who got pbt2 or a placebo daily for 12 weeks. The agent did red...Prana Biotechnology Presents New Key Findings on PBT2
PBT2 Alters Biomarkers and Rapidly Improves Cognition in two distinct models of Alzheimer's Disease MELBOURNE, Australia - June 7, 2007 - Prana Biotechnology Limited (NASDAQ: PRAN / ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative d...Independent Study Corroborates Prana's Strategy to Treat Alzheimer's Disease Patients.
...inc. The findings provide an explanation as to how pbt2 has demonstrated the ability to restore normal fun... so reverse cognitive loss in animal models of AD. pbt2 has completed a Phase IIa study in Alzheimer's dis...cted by synaptic zinc, suggest that the benefit of pbt2 seen in the recent clinical trial may reflect this...